* Assertio Holdings Inc reported a quarterly adjusted loss of 3 cents per share for the quarter , higher than the same quarter last year, when the company reported EPS of -46 cents. The mean expectation of five analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -6 cents to -3 cents per share.
* Revenue fell 18% to $29.20 million from a year ago; analysts expected $28.87 million.
* Assertio Holdings Inc's reported EPS for the quarter was a loss of 3 cents.
* The company reported a quarterly loss of $2.92 million.
* Assertio Holdings Inc shares had fallen by 28.0% this quarter and lost 20.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 4.5% in the last three months.
* In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Assertio Holdings Inc is $3.00 This summary was machine generated from LSEG data November 12 at 03:41 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.05 -0.03 Beat
Jun. 30 2024 -0.03 -0.04 Missed
Mar. 31 2024 -0.03 -0.05 Missed
Dec. 31 2023 -0.02 -0.61 Missed
Comments